[go: up one dir, main page]

EP2870130A4 - Compositions et méthodes de traitement de la douleur modérée à aiguë - Google Patents

Compositions et méthodes de traitement de la douleur modérée à aiguë

Info

Publication number
EP2870130A4
EP2870130A4 EP13813543.9A EP13813543A EP2870130A4 EP 2870130 A4 EP2870130 A4 EP 2870130A4 EP 13813543 A EP13813543 A EP 13813543A EP 2870130 A4 EP2870130 A4 EP 2870130A4
Authority
EP
European Patent Office
Prior art keywords
moderate
compositions
treatment
methods
severe pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13813543.9A
Other languages
German (de)
English (en)
Other versions
EP2870130A2 (fr
Inventor
Mahesh Kandula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellix Bio Pvt Ltd
Original Assignee
Cellix Bio Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Pvt Ltd filed Critical Cellix Bio Pvt Ltd
Publication of EP2870130A2 publication Critical patent/EP2870130A2/fr
Publication of EP2870130A4 publication Critical patent/EP2870130A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP13813543.9A 2012-07-03 2013-06-23 Compositions et méthodes de traitement de la douleur modérée à aiguë Withdrawn EP2870130A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2682CH2012 2012-07-03
PCT/IB2013/055146 WO2014006529A2 (fr) 2012-07-03 2013-06-23 Compositions et méthodes de traitement de la douleur modérée à aiguë

Publications (2)

Publication Number Publication Date
EP2870130A2 EP2870130A2 (fr) 2015-05-13
EP2870130A4 true EP2870130A4 (fr) 2015-12-02

Family

ID=54188020

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13813543.9A Withdrawn EP2870130A4 (fr) 2012-07-03 2013-06-23 Compositions et méthodes de traitement de la douleur modérée à aiguë

Country Status (8)

Country Link
EP (1) EP2870130A4 (fr)
JP (1) JP2015527309A (fr)
CN (1) CN104583162A (fr)
AU (1) AU2013285126A1 (fr)
CA (1) CA2873018A1 (fr)
SG (1) SG11201407328TA (fr)
WO (1) WO2014006529A2 (fr)
ZA (1) ZA201408057B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104379589A (zh) * 2012-05-07 2015-02-25 塞利克斯比奥私人有限公司 抗血小板药剂的前药
WO2016046674A1 (fr) * 2014-09-28 2016-03-31 Mohan M Alapati Compositions et procédés pour le traitement de douleur modérée à aiguë
CN105037241B (zh) * 2015-06-19 2018-02-23 上海上药新亚药业有限公司 1‑(2,6‑二氯苯基)‑2‑吲哚酮的合成工艺
CN111116391A (zh) * 2019-12-17 2020-05-08 浙江工业大学 一种2-[(2,6-二氯苯基)氨基]苯乙酸钠的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132318A (en) * 1966-03-30 1968-10-30 Geigy Ag J R New substituted phenylacetic esters, their production and compositions containing them
GB1582420A (en) * 1977-05-11 1981-01-07 Ciba Geigy Ag Phenylamino phenylacetic acid amide compounds and processes for their preparation
WO2009037707A2 (fr) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. Dérivés de l'acide n-phénylanthranilique et leurs utilisations
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514991B2 (en) * 1976-05-26 1981-03-12 Commonwealth Of Australia, The Pharmaceutical compositions containing antiinflammatory analgesic compounds
JPS5412340A (en) * 1977-06-27 1979-01-30 Daito Koeki Process for preparing phenylacetate derivative
NL8602767A (nl) * 1986-10-31 1988-05-16 Gantax Nv Organisch zuuranhydride, alsmede farmaceutisch preparaat op basis van een prodrug.
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH1143467A (ja) * 1997-05-14 1999-02-16 Ikeda Mohandou:Kk 脂肪酸グリセライド誘導体及びグリセライド誘導体、並びにそれらの製造方法
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
CN101186583B (zh) * 2007-12-20 2011-05-11 吉林大学 2-(2-(2,6-二氯苯基氨基)苯基)醋酸甲酯及其合成方法及其应用
BRPI0901298A2 (pt) * 2009-04-06 2011-01-04 Ems Sa derivados ftalimìdicos de compostos antiinflamatórios não-esteróide e/ou moduladores de tnf-(alfa), processo de sua obtenção, composições farmacêuticas contendo os mesmos e seus usos no tratamento de doenças inflamatórias
US9525998B2 (en) * 2012-01-06 2016-12-20 Qualcomm Incorporated Wireless display with multiscreen service
KR102094050B1 (ko) * 2012-01-27 2020-03-27 인터디지탈 패튼 홀딩스, 인크 다중 캐리어 기반형 및/또는 의사 조합형 네트워크에서 epdcch를 제공하는 시스템 및/또는 방법
CN104379589A (zh) * 2012-05-07 2015-02-25 塞利克斯比奥私人有限公司 抗血小板药剂的前药
CA2872975A1 (fr) * 2012-05-07 2013-11-14 Cellixbio Private Limited Compositions et methodes de traitement de troubles neurologiques
EP2847175A4 (fr) * 2012-05-08 2016-04-20 Cellix Bio Private Ltd Compositions et méthodes inhibant l'activité de l'anhydrase carbonique
JP2015526385A (ja) * 2012-05-08 2015-09-10 セリックスビオ プライヴェート リミテッド てんかんの治療のための組成物及び方法
WO2013167987A1 (fr) * 2012-05-08 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement du diabète
EP2882427A2 (fr) * 2012-05-08 2015-06-17 Cellixbio Private Limited Compositions et méthodes de traitement de troubles neurologiques

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132318A (en) * 1966-03-30 1968-10-30 Geigy Ag J R New substituted phenylacetic esters, their production and compositions containing them
GB1582420A (en) * 1977-05-11 1981-01-07 Ciba Geigy Ag Phenylamino phenylacetic acid amide compounds and processes for their preparation
WO2009037707A2 (fr) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. Dérivés de l'acide n-phénylanthranilique et leurs utilisations
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac

Also Published As

Publication number Publication date
EP2870130A2 (fr) 2015-05-13
CA2873018A1 (fr) 2014-01-09
WO2014006529A3 (fr) 2014-04-24
WO2014006529A2 (fr) 2014-01-09
JP2015527309A (ja) 2015-09-17
ZA201408057B (en) 2016-03-30
CN104583162A (zh) 2015-04-29
AU2013285126A1 (en) 2014-11-27
SG11201407328TA (en) 2014-12-30

Similar Documents

Publication Publication Date Title
IL266582A (en) Preparations and methods for the treatment of hemoglobin diseases
EP2836270A4 (fr) Systèmes et procédés liés au traitement de la douleur dorsale
HUE041553T2 (hu) Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
EP2831001A4 (fr) Compositions de traitement des eaux et procédés d'utilisation
IL221476A0 (en) Methods and compositions to treat hemorrhagic conditions of the brain
IL238177A0 (en) Methods and preparations for the treatment of cancer
EP2654745A4 (fr) Composition pour le traitement d'états pathologiques de la peau
ZA201408055B (en) Compositions and methods for the treatment of local pain
EP2616094A4 (fr) Traitement des lésions provoquées par une pénétration du cerveau
IL234606B (en) Innovative methods and compounds for the treatment of diseases
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
HK1208598A1 (en) Methods and compositions for treating pain
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
EP2958591A4 (fr) Procédés et compositions associés au traitement du cancer
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
ZA201408065B (en) Compositions and methods for the treatment of diabetes
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
SG11201504779YA (en) Methods and compositions relating to treatment of cancer
EP2825184A4 (fr) Compositions et méthodes pour le traitement de la douleur
EP2916831A4 (fr) Compositions de milieu de contraste pour radiographie et leurs procédés d'utilisation pour traiter une inflammation et des états associés à une inflammation.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150203

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20151102

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 29/00 20060101ALI20151027BHEP

Ipc: A61K 31/02 20060101ALI20151027BHEP

Ipc: A61P 25/04 20060101ALI20151027BHEP

Ipc: C07C 25/08 20060101AFI20151027BHEP

Ipc: A61K 31/136 20060101ALI20151027BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160913